The FBI blamed the 2001 anthrax attacks on the wrong man, and the true origin is being obscured

The case that was never tested

Start with what should trouble even a cautious reader: the accused was never charged, and he was already dead when he was named. Dr. Bruce Ivins, a biodefense microbiologist at the Army's USAMRIID laboratory at Fort Detrick, died on 29 July 2008 of an apparent overdose, days after learning charges were coming. A week later, prosecutors held a press conference to announce that he had been the sole perpetrator all along. There was no arrest, no indictment tested in court, no cross-examination, and no defense. The strongest safeguard against a mistaken accusation, a trial, never took place.

Then there is the science, which the FBI itself submitted for outside review. In 2008 the Bureau asked the National Academy of Sciencesto examine the technical case, presumably expecting validation. What it got, in the Academy's February 2011report, was a careful refusal to go as far as the FBI had. The reviewers accepted that the anthrax was the Ames strain and that four genetic mutations found in the letters also appeared in Ivins's flask, known as RMR-1029. But they concluded that this established an association, not proof of origin: the evidence, they wrote, “did not definitively demonstrate” that the mailed spores were grown from that flask, and it was “not possible to reach a definitive conclusion about the origins” of the material from the science alone.

The FBI asked the National Academy of Sciences to certify its science, and the Academy declined to say the evidence pointed conclusively at Ivins's flask.

The flask was not a private object, either. RMR-1029 and its genetic markers had been shared with other institutions, and by the FBI's own account something like a hundred people had some form of access to the material or its descendants. The genetics could narrow the field to that shared lineage; they could not, the Academy found, pick one man out of it. A later Government Accountability Officereview in 2014 added that the validation and statistical methods behind the genetic tests “could be improved,” and that the FBI had lacked a consistent framework across the contractors who developed them.

And the technical objections did not stop at genetics. The powder in the Senate letters was strikingly pure and fine, and independent scientists have long argued that producing it in that quantity and quality, without leaving a trace, would have been very hard for one researcher working alone with the equipment Ivins had. That is a claim the official account never fully put to rest.

What the FBI actually assembled

The doubts are real, but so is the case the FBI built, and honesty requires laying it out rather than waving it away. The Bureau did not pick Ivins at random. Its 2010 Investigative Summary assembled a dense circumstantial narrative, and taken together it is not trivial.

The spine of it was the flask. Years of genetic work traced the distinctive mutations in the attack powder to RMR-1029, a specific preparation of Ames-strain anthrax that Ivins had created and controlled at USAMRIID. From there the investigators layered on behavior: Ivins had logged an unusual pattern of late-night, solo hours in the high-containment lab in the weeks immediately before each mailing, hours that departed sharply from his normal routine and that he could not, in the FBI's view, adequately explain. When first asked for a sample of his anthrax for the genetic database, he submitted material that the Bureau said did not properly represent his flask, which prosecutors read as an attempt to throw them off; his defenders read it as a paperwork failure, and later releases showed the picture was messier than first presented.

The FBI also pointed to Ivins's documented and serious mental-health struggles, including threatening statements and a history that a panel of forensic psychiatrists, reviewing his sealed records after his death, concluded was consistent with someone capable of the act. Prosecutors noted his professional stake in anthrax vaccine work at a moment when that program was faltering, offering a possible motive, and his connections to the geography of the mailings. None of these facts, on its own, was conclusive. The FBI's argument was that the accumulation, the flask, the hours, the sample, the psychology, the motive, pointed to one man.

It is worth stating plainly what this evidence is and is not. It is a serious, multi-strand circumstantial case that persuaded the career investigators who built it. It is not a courtroom verdict, and it was not certified as conclusive by the outside scientists the FBI itself invited to check it. Both of those things are true at once, and the disciplined reading holds them together rather than collapsing into either the Bureau's certainty or a flat rejection of it.

Why the doubt took hold and stayed

The reason this case did not close in the public mind when the FBI closed the file is that the investigation had already, visibly, been wrong once. Before Ivins there was Steven Hatfill, another former Army scientist, whom the Attorney General called a “person of interest” on television in 2002. Hatfill was never charged with anything. He was trailed by agents in the open, named again and again in the press, and had his life dismantled on suspicion. And he was innocent. The government exonerated him and, in 2008, paid roughly $5.8 millionto settle his lawsuit over the leaks about him. Anyone who watched that happen had a rational basis to distrust the Bureau's next confident announcement, and the next suspect could not benefit from the presumption the first one had been denied.

The subject matter did the rest. Anthrax grown in a US military laboratory, mailed to senators and anchors in the traumatized weeks after 9/11, touches every nerve at once: bioterror, the government's own weapons work, the intelligence failures of that autumn, and the sense that powerful institutions do not tell the whole truth about their own programs. A lone, troubled scientist is a psychologically thin ending for a story that large. A hidden origin, by contrast, matches the scale of the fear.

What kept the doubt respectable, rather than fringe, was that credentialed people shared it out loud. Microbiologists who had worked beside Ivins said publicly they did not believe he had done it. A sustained 2011 investigation by PBS Frontline, ProPublica, and McClatchy, working through the released files, found gaps and contradictions in the government's account, and reported that even some of the FBI's own scientific consultants wondered whether the real perpetrator was still at large. When the dissent comes from inside the field and from mainstream newsrooms, it does not read as paranoia. It reads as an open question.